| MeSH term | MeSH ID | Detail |
|---|---|---|
| Starvation | D013217 | 47 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
Total
2
D-cycloserine
D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.
Cross Reference
Introduction
To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with D-cycloserine?
D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with D-cycloserine
PubChem Associated disorders and diseases
What pathways are associated with D-cycloserine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with D-cycloserine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with D-cycloserine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with D-cycloserine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with D-cycloserine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with D-cycloserine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with D-cycloserine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Luyirika E et al. | A home-based approach to managing multi-drug resistant tuberculosis in Uganda: a case report. | 2012 | AIDS Res Ther | pmid:22524486 |
| Bhagwan S and Naidoo K | Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis. | 2011 | AIDS Res Treat | pmid:22216407 |
| Bienkowski P et al. | Discriminative stimulus effects of ethanol: lack of antagonism with N-methyl-D-aspartate and D-cycloserine. | 1997 Jul-Aug | Alcohol | pmid:9209549 |
| Vengeliene V et al. | D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats. | 2008 Nov-Dec | Alcohol Alcohol. | pmid:18945754 |
| Moraes Ferreira VM and Morato GS | D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze. | 1997 | Alcohol. Clin. Exp. Res. | pmid:9438524 |
| Debrouse L et al. | Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site. | 2013 | Alcohol. Clin. Exp. Res. | pmid:22934986 |
| Groblewski PA et al. | Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice. | 2009 | Alcohol. Clin. Exp. Res. | pmid:19298331 |
| Trevisan L et al. | Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors. | 2008 | Alcohol. Clin. Exp. Res. | pmid:18028532 |
| Thong BY | Update on the management of antibiotic allergy. | 2010 | Allergy Asthma Immunol Res | pmid:20358021 |
| Randolph C et al. | D-cycloserine treatment of Alzheimer disease. | 1994 | Alzheimer Dis Assoc Disord | pmid:7986489 |
| Santa Ana EJ et al. | D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. | 2015 | Am J Addict | pmid:25808169 |
| Price KL et al. | D-cycloserine and cocaine cue reactivity: preliminary findings. | 2009 | Am J Drug Alcohol Abuse | pmid:20014913 |
| Hofmann SG et al. | Effects of D-cycloserine on craving to alcohol cues in problem drinkers: preliminary findings. | 2012 | Am J Drug Alcohol Abuse | pmid:21851195 |
| Peloquin CA and Berning SE | Advice on treatment of drug-resistant tuberculosis. | 1997 | Am J Health Syst Pharm | pmid:9075505 |
| Posey DJ et al. | A pilot study of D-cycloserine in subjects with autistic disorder. | 2004 | Am J Psychiatry | pmid:15514414 |
| Goff DC et al. | D-cycloserine added to clozapine for patients with schizophrenia. | 1996 | Am J Psychiatry | pmid:8942463 |
| Shim SS et al. | D-cycloserine augmentation for behavioral therapy. | 2008 | Am J Psychiatry | pmid:18676606 |
| Tsai GE et al. | Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. | 1999 | Am J Psychiatry | pmid:10080566 |
| Heresco-Levy U et al. | Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. | 2002 | Am J Psychiatry | pmid:11870017 |
| Kantrowitz JT et al. | d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine. | 2016 | Am J Psychiatry | pmid:27903101 |
| Warren ZE et al. | Identity crisis involving body image in a young man with autism. | 2010 | Am J Psychiatry | pmid:21041252 |
| Rothbaum BO et al. | A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. | 2014 | Am J Psychiatry | pmid:24743802 |
| Hofmann SG et al. | D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. | 2013 | Am J Psychiatry | pmid:23599046 |
| Neylan TC | Pharmacologic augmentation of extinction learning during exposure therapy for PTSD. | 2014 | Am J Psychiatry | pmid:24880503 |
| Javitt DC | Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. | 2013 | Am J Psychiatry | pmid:23820828 |
| Van Kammen DP | gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia. | 1977 | Am J Psychiatry | pmid:835733 |
| Buchanan RW et al. | The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. | 2007 | Am J Psychiatry | pmid:17898352 |
| Rothbaum BO et al. | Response to Smith. | 2014 | Am J Psychiatry | pmid:25756637 |
| Goff DC et al. | Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. | 1995 | Am J Psychiatry | pmid:7625475 |
| Smith E | Possible negative effects of extinction learning on outcomes for patients receiving exposure therapy. | 2014 | Am J Psychiatry | pmid:25756636 |
| Rothbaum BO and Ressler K | Response to Granoff. | 2014 | Am J Psychiatry | pmid:25756635 |
| Granoff AL | The impact of benzodiazepine management in the randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy. | 2014 | Am J Psychiatry | pmid:25756634 |
| Wilhelm S et al. | Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. | 2008 | Am J Psychiatry | pmid:18245177 |
| Rothbaum BO | Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder. | 2008 | Am J Psychiatry | pmid:18316423 |
| Tabarsi P et al. | Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases. | 2011 | Am J Ther | pmid:20535008 |
| Baghaei P et al. | Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran. | Am J Ther | pmid:20019591 | |
| STEENKEN W and WOLINSKY E | Cycloserine: antituberculous activity in vitro and in the experimental animal. | 1956 | Am Rev Tuberc | pmid:13302684 |
| HOEPRICH PD | ALANINE: CYCLOSERINE ANTAGONISM. I. SIGNIFICANCE OF PHENOMENON IN TESTING SUSCEPTIBILITY TO CYCLOSERINE. | 1964 | Am. J. Clin. Pathol. | pmid:14124671 |
| Hoeprich PD et al. | Nocardial brain abscess cured with cycloserine and sulfonamides. | 1968 | Am. J. Med. Sci. | pmid:5644095 |
| WIEDMAN M and TURTZ AI | Antibiotics in herpes simplex and an experimental and clinical investigation of cycloserine. | 1959 | Am. J. Ophthalmol. | pmid:13844589 |
| Jacobs LS and Kester M | Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells. | 1993 | Am. J. Physiol. | pmid:8214030 |
| Baldwin EW et al. | Efficacy of certain chemical agents in the treatment of leptospiruria in hamsters. | 1972 | Am. J. Vet. Res. | pmid:4111742 |
| Fischer DA et al. | Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases. | 1968 | Am. Rev. Respir. Dis. | pmid:5638494 |
| Heifets L | Qualitative and quantitative drug-susceptibility tests in mycobacteriology. | 1988 | Am. Rev. Respir. Dis. | pmid:3195815 |
| Hawkins JE and McClean VR | Effect of d-alanine on cycloserine blood levels in laboratory animals. | 1966 | Am. Rev. Respir. Dis. | pmid:5910683 |
| Ethambutol in re-treatment of pulmonary tuberculosis. | 1968 | Am. Rev. Respir. Dis. | pmid:4300827 | |
| Steiner P et al. | Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn. | 1974 | Am. Rev. Respir. Dis. | pmid:4209361 |
| CONN HO et al. | ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. | 1964 | Am. Rev. Respir. Dis. | pmid:14221666 |
| Kuze F | Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. | 1984 | Am. Rev. Respir. Dis. | pmid:6703503 |
| David HL | Susceptibility of mycobacterium intracellulare to O-carbamyl-D-serine. | 1970 | Am. Rev. Respir. Dis. | pmid:5427392 |